FRANK W GAY II Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANK W GAY II.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANK W GAY II. FRANK W GAY II is Chairman & CEO in NUTRACEUTICAL INTERNATIONAL CORP ($NUTR) and Chairman and CEO in NUTRACEUTICAL INTERNATIONAL CORP ($NUTR).
Latest Insider Trading Transactions of FRANK W GAY II
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 24 2017 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman and CEO | Option Exercise | D | 0.00 | 42,000 | 0 | 0 | |
Aug 24 2017 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman and CEO | Sell | D | 0.00 | 120 | 0 | 0 | 120 to 0 (-100.00 %) |
Aug 24 2017 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman and CEO | Sell | D | 0.00 | 734,769 | 0 | 0 | 734.8 K to 0 (-100.00 %) |
Aug 24 2017 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman and CEO | Gift | G | 0.00 | 5,000 | 0 | 734,769 | 739.8 K to 734.8 K (-0.68 %) |
Dec 16 2016 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Grant | A | 34.50 | 9,275 | 319,988 | 739,769 | 730.5 K to 739.8 K (+1.27 %) |
Dec 28 2015 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 5,000 | 0 | 730,494 | 735.5 K to 730.5 K (-0.68 %) |
Dec 15 2015 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Grant | A | 24.51 | 4,080 | 100,001 | 735,494 | 731.4 K to 735.5 K (+0.56 %) |
Dec 15 2014 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Grant | A | 20.28 | 4,093 | 83,006 | 742,414 | 738.3 K to 742.4 K (+0.55 %) |
Dec 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Grant | A | 0.00 | 4,922 | 0 | 738,321 | 733.4 K to 738.3 K (+0.67 %) |
Sep 23 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 2,795 | 34,434 | 0 | |
Sep 23 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 7,205 | 88,766 | 2,795 | |
Sep 23 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 23.10 | 2,795 | 64,559 | 733,399 | 736.2 K to 733.4 K (-0.38 %) |
Sep 23 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 2,795 | 34,434 | 736,194 | 733.4 K to 736.2 K (+0.38 %) |
Sep 23 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 23.37 | 7,205 | 168,363 | 733,399 | 740.6 K to 733.4 K (-0.97 %) |
Sep 23 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 23.37 | 7,205 | 168,363 | 740,604 | 733.4 K to 740.6 K (+0.98 %) |
Jun 28 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 10,849 | 133,660 | 10,000 | |
Jun 28 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.25 | 10,849 | 219,692 | 733,399 | 744.2 K to 733.4 K (-1.46 %) |
Jun 28 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 10,849 | 133,660 | 744,248 | 733.4 K to 744.2 K (+1.48 %) |
Jun 21 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 5,471 | 67,403 | 20,849 | |
Jun 21 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 401 | 4,940 | 26,320 | |
Jun 21 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.25 | 5,471 | 110,788 | 733,399 | 738.9 K to 733.4 K (-0.74 %) |
Jun 21 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 5,471 | 67,403 | 738,870 | 733.4 K to 738.9 K (+0.75 %) |
Jun 21 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.25 | 401 | 8,120 | 733,399 | 733.8 K to 733.4 K (-0.05 %) |
Jun 21 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 401 | 4,940 | 733,800 | 733.4 K to 733.8 K (+0.05 %) |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 1,732 | 21,338 | 26,721 | |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 246 | 3,031 | 28,453 | |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 15,143 | 186,562 | 28,699 | |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.13 | 1,732 | 34,863 | 733,399 | 735.1 K to 733.4 K (-0.24 %) |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | S | 12.32 | 1,732 | 21,338 | 735,131 | 733.4 K to 735.1 K (+0.24 %) |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.06 | 246 | 4,934 | 733,399 | 733.6 K to 733.4 K (-0.03 %) |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 246 | 3,031 | 733,645 | 733.4 K to 733.6 K (+0.03 %) |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.07 | 15,143 | 303,962 | 733,399 | 748.5 K to 733.4 K (-2.02 %) |
Jun 17 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 15,143 | 186,562 | 748,542 | 733.4 K to 748.5 K (+2.06 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 1,050 | 12,936 | 43,842 | |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 3,048 | 37,551 | 44,892 | |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 12.32 | 12,060 | 148,579 | 47,940 | |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.06 | 1,050 | 21,063 | 733,399 | 734.4 K to 733.4 K (-0.14 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 1,050 | 12,936 | 734,449 | 733.4 K to 734.4 K (+0.14 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.24 | 3,048 | 61,689 | 733,399 | 736.4 K to 733.4 K (-0.41 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 3,048 | 37,551 | 736,447 | 733.4 K to 736.4 K (+0.42 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.12 | 12,060 | 242,654 | 733,399 | 745.5 K to 733.4 K (-1.62 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 12.32 | 12,060 | 148,579 | 745,459 | 733.4 K to 745.5 K (+1.64 %) |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | W | 0.00 | 120 | 0 | 120 | 0 to 120 |
Jun 12 2013 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 10,000 | 0 | 733,399 | 743.4 K to 733.4 K (-1.35 %) |
Feb 07 2012 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 1,500 | 0 | 743,399 | 744.9 K to 743.4 K (-0.20 %) |
Feb 07 2012 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 1,500 | 0 | 744,899 | 746.4 K to 744.9 K (-0.20 %) |
Feb 07 2012 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 1,500 | 0 | 746,399 | 747.9 K to 746.4 K (-0.20 %) |
Feb 07 2012 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 10,000 | 0 | 747,899 | 757.9 K to 747.9 K (-1.32 %) |
Dec 09 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 30,000 | 105,000 | 0 | |
Dec 09 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 30,000 | 105,000 | 757,899 | 727.9 K to 757.9 K (+4.12 %) |
Oct 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 2,700 | 9,450 | 30,000 | |
Oct 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.50 | 2,700 | 36,455 | 727,899 | 730.6 K to 727.9 K (-0.37 %) |
Oct 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 2,700 | 9,450 | 730,599 | 727.9 K to 730.6 K (+0.37 %) |
Oct 19 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 3,543 | 12,401 | 32,700 | |
Oct 19 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 2,757 | 9,650 | 36,243 | |
Oct 19 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.00 | 3,543 | 46,059 | 727,899 | 731.4 K to 727.9 K (-0.48 %) |
Oct 19 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 3,543 | 12,401 | 731,442 | 727.9 K to 731.4 K (+0.49 %) |
Oct 19 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.06 | 2,757 | 36,002 | 727,899 | 730.7 K to 727.9 K (-0.38 %) |
Oct 19 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 2,757 | 9,650 | 730,656 | 727.9 K to 730.7 K (+0.38 %) |
Oct 17 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 13,700 | 47,950 | 39,000 | |
Oct 17 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.23 | 13,700 | 181,235 | 727,899 | 741.6 K to 727.9 K (-1.85 %) |
Oct 17 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 13,700 | 47,950 | 741,599 | 727.9 K to 741.6 K (+1.88 %) |
Oct 06 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 756 | 2,646 | 52,700 | |
Oct 06 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 2,344 | 8,204 | 53,456 | |
Oct 06 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.00 | 756 | 9,828 | 727,899 | 728.7 K to 727.9 K (-0.10 %) |
Oct 06 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 756 | 2,646 | 728,655 | 727.9 K to 728.7 K (+0.10 %) |
Oct 06 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.00 | 2,344 | 30,472 | 727,899 | 730.2 K to 727.9 K (-0.32 %) |
Oct 06 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 2,344 | 8,204 | 730,243 | 727.9 K to 730.2 K (+0.32 %) |
Sep 30 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 1,300 | 4,550 | 55,800 | |
Sep 30 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.12 | 1,300 | 17,050 | 727,899 | 729.2 K to 727.9 K (-0.18 %) |
Sep 30 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 1,300 | 4,550 | 729,199 | 727.9 K to 729.2 K (+0.18 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.47 | 5,900 | 79,461 | 727,899 | 733.8 K to 727.9 K (-0.80 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 5,900 | 20,650 | 733,799 | 727.9 K to 733.8 K (+0.81 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.24 | 7,000 | 92,680 | 727,899 | 734.9 K to 727.9 K (-0.95 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 7,000 | 24,500 | 734,899 | 727.9 K to 734.9 K (+0.96 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 13.24 | 5,000 | 66,194 | 727,899 | 732.9 K to 727.9 K (-0.68 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 5,000 | 17,500 | 732,899 | 727.9 K to 732.9 K (+0.69 %) |
Sep 27 2011 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 13,000 | 0 | 727,899 | 740.9 K to 727.9 K (-1.75 %) |
Dec 28 2009 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 6,000 | 0 | 740,899 | 746.9 K to 740.9 K (-0.80 %) |
Mar 11 2009 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.50 | 25,000 | 87,500 | 75,000 | |
Mar 11 2009 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.50 | 25,000 | 87,500 | 746,899 | 721.9 K to 746.9 K (+3.46 %) |
Mar 11 2009 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 4,000 | 0 | 721,899 | 725.9 K to 721.9 K (-0.55 %) |
Mar 11 2009 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 4,000 | 0 | 725,899 | 729.9 K to 725.9 K (-0.55 %) |
Mar 11 2009 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 4,000 | 0 | 729,899 | 733.9 K to 729.9 K (-0.55 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 24,606 | 84,972 | 0 | |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 18,321 | 63,268 | 24,606 | |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 30,000 | 103,599 | 42,927 | |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 25.99 | 24,606 | 639,537 | 742,899 | 767.5 K to 742.9 K (-3.21 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 24,606 | 84,972 | 767,505 | 742.9 K to 767.5 K (+3.31 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.45 | 18,321 | 447,923 | 742,899 | 761.2 K to 742.9 K (-2.41 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 18,321 | 63,268 | 761,220 | 742.9 K to 761.2 K (+2.47 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.33 | 30,000 | 729,924 | 742,899 | 772.9 K to 742.9 K (-3.88 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 30,000 | 103,599 | 772,899 | 742.9 K to 772.9 K (+4.04 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 24,606 | 84,972 | 0 | |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 18,321 | 63,268 | 24,606 | |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 30,000 | 103,599 | 42,927 | |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 25.99 | 24,606 | 639,537 | 742,899 | 767.5 K to 742.9 K (-3.21 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 24,606 | 84,972 | 767,505 | 742.9 K to 767.5 K (+3.31 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.45 | 18,321 | 447,923 | 742,899 | 761.2 K to 742.9 K (-2.41 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 18,321 | 63,268 | 761,220 | 742.9 K to 761.2 K (+2.47 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.33 | 30,000 | 729,924 | 742,899 | 772.9 K to 742.9 K (-3.88 %) |
Jun 04 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 30,000 | 103,599 | 772,899 | 742.9 K to 772.9 K (+4.04 %) |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 10,037 | 34,661 | 72,927 | |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 1,800 | 6,216 | 82,964 | |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 7,010 | 24,208 | 84,764 | |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.05 | 10,037 | 241,388 | 742,899 | 752.9 K to 742.9 K (-1.33 %) |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 10,037 | 34,661 | 752,936 | 742.9 K to 752.9 K (+1.35 %) |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.00 | 1,800 | 43,200 | 742,899 | 744.7 K to 742.9 K (-0.24 %) |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 1,800 | 6,216 | 744,699 | 742.9 K to 744.7 K (+0.24 %) |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.04 | 7,010 | 168,552 | 742,899 | 749.9 K to 742.9 K (-0.93 %) |
May 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 7,010 | 24,208 | 749,909 | 742.9 K to 749.9 K (+0.94 %) |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 12,171 | 42,030 | 91,774 | |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 12,554 | 43,353 | 103,945 | |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 10,064 | 34,754 | 116,499 | |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.05 | 12,171 | 292,728 | 742,899 | 755.1 K to 742.9 K (-1.61 %) |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 12,171 | 42,030 | 755,070 | 742.9 K to 755.1 K (+1.64 %) |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.10 | 12,554 | 302,541 | 742,899 | 755.5 K to 742.9 K (-1.66 %) |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 12,554 | 43,353 | 755,453 | 742.9 K to 755.5 K (+1.69 %) |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 24.05 | 10,064 | 242,001 | 742,899 | 753 K to 742.9 K (-1.34 %) |
May 19 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 10,064 | 34,754 | 752,963 | 742.9 K to 753 K (+1.35 %) |
Mar 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | M | 3.45 | 61,665 | 212,948 | 126,563 | |
Mar 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Sell | S | 20.03 | 61,665 | 1,235,292 | 742,899 | 804.6 K to 742.9 K (-7.66 %) |
Mar 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Buy | M | 3.45 | 61,665 | 212,948 | 804,564 | 742.9 K to 804.6 K (+8.30 %) |
Mar 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 5,500 | 0 | 742,899 | 748.4 K to 742.9 K (-0.73 %) |
Mar 24 2004 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Gift | G | 0.00 | 4,500 | 0 | 748,399 | 752.9 K to 748.4 K (-0.60 %) |
Dec 19 2003 | NUTR | NUTRACEUTICAL INTE ... | GAY FRANK W II | Chairman & CEO | Option Exercise | A | 12.32 | 60,000 | 739,200 | 60,000 |
Page: 1